TMRW Life Sciences pockets $105m Series C
TMRW Life Sciences Inc, a provider of an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization, has raised $105 million in Series C financing.
TMRW Life Sciences Inc, a provider of an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization, has raised $105 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination